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Background/aim: Curcumin, a naturally occurring antioxidant, shows a wide variety of medicinal properties. The possibility of utilizing
curcumin as an additive in storage solutions of blood has not been explored. The purpose of this study was to analyze the effect of
curcumin on erythrocytes during storage.
Materials and methods: Blood obtained from rats was stored (4 °C) for 20 days in citrate-phosphate-dextrose-adenine-1 solution.
Samples were divided into four groups: 1) Controls; 2) Curcumin 10 mM; 3) Curcumin 30 mM; and 4) Curcumin 60 mM. Every
fifth day, hemoglobin, superoxide, antioxidant enzymes (superoxide dismutase, catalase, and glutathione peroxidase (GSH-Px)), lipid
peroxidation (conjugate dienes and malondialdehyde (MDA)), protein oxidation (advanced oxidation protein products (AOPP) and
sulfhydryls (P-SH)), and hemolysis were analyzed.
Results: Hemoglobin was successfully maintained, while superoxide dismutase increased initially and decreased towards the end of
storage. Superoxide, catalase, GSH-Px, conjugate dienes, and AOPP were lower in the curcumin groups than they were in the controls.
MDA was higher in the curcumin groups than in the controls. P-SH increased in the curcumin groups, while hemolysis increased in
all groups.
Conclusion: Curcumin maintained hemoglobin and modulated antioxidant enzymes throughout storage. However, curcumin could not
protect all proteins and lipids from oxidative damage completely. This study opens up new avenues for using curcumin, in combination
with other antioxidants, as a component in storage solutions.
Key words: Erythrocytes, storage, curcumin, antioxidant, lipid peroxidation, protein oxidation

1. Introduction
Different extracts and compounds from the Curcuma longa
plant have been used extensively as culinary and medicinal
ingredients. The rhizomes of these plants contain turmerin,
essential oils, and curcuminoids (1). Curcuminoids are
a group of phenolic compounds, constituting about
5% of the turmeric rhizome (2) such as curcumin,
demethoxycurcumin, and bisdemethoxycurcumin (3).
Curcumin (diferuloylmethane) is the principle coloring
agent (4), imparting an orange yellow color (5). The yellow
color is attributed to its unique conjugated structure,
including two methoxylated phenols and the enol form
of a heptadiene-3, 5-diketone linking the two phenols (6).
Curcumin has been shown to exhibit a wide plethora of
properties, ranging from antioxidant to anticarcinogenic
(7–11). The therapeutic effects of curcumin are due to its
strong antioxidant property (6), which is in turn due to
its unique structure (12). Curcumin has been found to
be at least ten times more potent than Vitamin E (13).
Curcumin is a powerful free radical scavenger (hydrogen
* Correspondence: tiwari.vani@gmail.com

peroxide, singlet oxygen, hydroxyl, superoxide, peroxyl,
peroxynitrite, and nitrite radicals) (14–22) and neutralizes
2,2-diphenyl-1-picrylhydrazyl (20,22–24). Curcumin has
both antioxidant and prooxidant effects in oxygen radical
reactions, acting as a scavenger of hydroxyl radicals or a
catalyst in the formation of hydroxyl radicals, depending
on the experimental conditions (19,25–27). It protects
oxyhemoglobin from nitrite-induced oxidation (7,10).
Curcumin is an inhibitor of lipid peroxidation (10,2832), reducing oxidative damage through its capacity
to efficiently scavenge lipid peroxyl radicals, thereby
protecting membrane lipids (2,33). Curcumin increases
intracellular glutathione (GSH) and regulates antioxidant
enzymes (29,31).
In rat erythrocytes, curcumin inhibited reactive
oxygen species (ROS) generation (25) and decreased
osmotic fragility (34) and hemolysis (22). Banerjee
et al. (35) studied the effects of curcumin on AAPHinduced hemolysis of red blood cells (RBCs), showing
a concentration-dependent decrease in TBARS and
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hemolysis on treatment with curcumin. However, the
effects of curcumin on storage-induced oxidative stress in
erythrocytes have not been reported.
Hence, this study elucidates the action of curcumin on
erythrocytes of stored blood by: 1) analyzing oxidant levels
through hemoglobin (Hb), hemolysis, lipid peroxidation,
and protein oxidation; and 2) determining antioxidant
status through antioxidant enzymes-superoxide dismutase,
catalase (CAT), and glutathione peroxidase (GSH-Px).
2. Materials and methods
Animal care and maintenance was in accordance with
ethical committee regulations.
2.1. Chemicals
Hb reagent was obtained from Coral Clinical Systems.
Thiobarbituric acid, epinephrine, glutathione reductase,
GSH, curcumin, and bovine serum albumin were
purchased from Sigma-Aldrich Chemicals. All other
chemicals used were of reagent grade and organic solvents
were of spectral grade.
2.2. Blood sampling
Animals were lightly anaesthetized with ether and
restrained in dorsal recumbency as described earlier (36).
In brief, the syringe needle was inserted just below the
xiphoid cartilage and slightly to the left of midline. Blood
was carefully aspirated from the heart into plastic collecting
tubes with citrate-phosphate-dextrose-adenine-1 solution.
2.3. Experimental design
Blood was drawn from Wistar rats (4 months old) and
stored over a period of time (15 days) at 4 °C in citratephosphate-dextrose-adenine-1 solution. Blood was
collected from 20 animals and divided into the following
four groups (with 5 animals in each group): 1) control
group; 2) Cur 10-samples with curcumin as additive at a
concentration of 10 mM; 3) Cur 30-samples with curcumin
as additive at a concentration of 30 mM; and 4) Cur
60-samples with curcumin as additive at a concentration
of 60 mM. Erythrocytes were isolated from stored blood
at regular intervals (every fifth day) and the biomarkers of
oxidative stress (OS) were studied.
2.4. Erythrocyte separation
Erythrocytes were isolated by centrifugation for 20 min at
1000 g at 4 °C. Plasma and buffy coat were removed using
a micropipette. The cell pellet was washed three times with
isotonic phosphate buffer, pH 7.4, centrifuged at 1000
g for 10 min, and finally suspended in an equal volume
of isotonic phosphate buffer (37). This constituted the
erythrocyte suspension.
2.5. Hb estimation
Hb was measured using Hemocor-D Kit (Coral Clinical
Systems), which utilizes the cyanmethemoglobin method
(38). Whole blood was incubated with Hb reagent for 3
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min at room temperature and absorbance was measured
at 540 nm. Hb concentration was represented in terms of
g dL–1.
2.6. Superoxide
The superoxide generated in the samples was determined
by the method of Olas and Wachowisz (39). Cytochrome
c (160 µM) was added to equal volume of sample and
incubated at 37 °C for 5 to 15 min. The samples were then
centrifuged at 3500 rpm for 5 min. The absorbance of the
supernatant was measured at 550 nm.
2.7. Antioxidant enzymes
2.7.1. Superoxide dismutase (SOD, EC 1.15.1.1)
SOD was measured by the method of Misra and Fridovich
(40). Hemolysate was added to carbonate buffer (0.05
M). Epinephrine was added to the mixture and measured
(ELICO, Model SL 159) at 480 nm. SOD activity is
expressed as the amount of enzyme that inhibits oxidation
of epinephrine by 50%.
2.7.2. CAT (EC 1.11.1.6)
CAT was determined by the method of Aebi (41). Briefly,
hemolysate with absolute alcohol was incubated at 0 °C.
An aliquot was taken up with 6.6 mM H2O2 and decrease
in absorbance was measured at 240 nm. An extinction
coefficient of 43.6 Mcm–1 was used to determine enzyme
activity.
2.7.3. GSH-Px (EC.1.11.1.9)
GSH-Px was analyzed by the method of Flohe and Gunzler
(42). Fifty microliters of 0.1 M phosphate buffer (pH 7.0),
100 µL of enzyme sample, 100 µL of glutathione reductase
(0.24 units), and 100 µL of 10 mM GSH were mixed and
preincubated for 10 min at 37 °C, followed by addition of
100 µL of 1.5 mM NADPH in 0.1% NaHCO3. The overall
reaction was started by adding 100 µL of prewarmed
hydrogen peroxide and decrease in absorption at 340 nm
was monitored for 3 min.
2.8. Lipid peroxidation
2.8.1. Conjugate dienes
The primary marker of lipid peroxidation, conjugate
dienes, was assessed by the method of Olas and Wachowisz
(39). Briefly, the samples were diluted 5 times in ether :
ethanol (1:3 v/v), vortexed for 1 min, and centrifuged at
8000 rpm for 20 min; the supernatant was analyzed in a
spectrophotometer at 234 nm. The amount of conjugate
dienes produced was calculated using the molar extinction
coefficient of 29,500 M–1cm–1.
2.8.2. Malondialdehyde (MDA)
MDA, a product of lipid peroxidation, was determined
according to the method of Ohkawa et al. (43). The sample
was added to 8.1% SDS, vortexed, and incubated at room
temperature. This was followed by addition of 20% acetic
acid and 0.6% thiobarbituric acid and placement in
boiling water bath. The sample was allowed to cool and
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3. Results
3.1. Hb
Changes in Hb were significant during the storage period.
Controls showed an increase of 100% (day 10) and a final
reduction of 22% on day 15. Decrements of 20% (day 5) in
Cur 10 and 72% (day 10) and 22% (day 15) in Cur 30 were
observed. Cur 60 showed decreases of 53% and 16% on
days 10 and 15, respectively.
Hb decreased by 35% (day 10) and increased by 55%
(day 15) in Cur 10 against the controls. Cur 30 and Cur 60
showed reductions on day 10 by 70% against control and
Cur 10 samples (Figure 1).
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butanol-pyridine was added and centrifuged. Absorbance
of the colored layer was measured at 532 nm with 1, 1, 3,
3-tetramethoxy propane as a standard.
2.9. Protein oxidation
2.9.1. Advanced oxidation protein products (AOPP)
Spectrophotometric determination of AOPP levels was
assayed as an index of dityrosine containing cross-linked
protein products using a method proposed by Witko et al.
(44). Hemolysate was diluted in phosphate buffered saline
and 1.16 M/l of potassium iodide was added; this was
followed by the addition of acetic acid. The absorbance
of the reaction mixture was immediately read at 340 nm.
AOPP was calculated by using the extinction coefficient of
26 mM–1cm–1.
2.9.2. Sulfhydryls (P-SH)
P-SH in lysate was measured as described by Habeeb (45).
In brief, 0.08 mol/L sodium phosphate buffer containing
0.5 mg/mL Na2-EDTA and 2% SDS were added to
each assay tube; 0.1 mL of 5, 5’ DTNB was also added.
Absorbance was measured at 412 nm.
2.10. Hemolysis
A 5% suspension of packed erythrocytes in buffer was
mixed with equal volume of 8 mM H2O2. The mixtures
were incubated at 37 °C in a BOD incubator. Hemolysis was
determined by measuring released Hb into the supernatant
of the induced samples at 540 nm and expressed on the
basis of the maximum absorbance (100%) in the aliquots
of erythrocytes completely hemolyzed in distilled water
(46).
2.11. Protein determination
Protein was determined in the lysate and membrane
following a method described by Lowry et al. (47), using
bovine serum albumin as standard.
2.12. Statistical analyses
Results are represented as means ± SE. Values between
the groups were analyzed by two-way ANOVA and P <
0.05 was considered significant. Bonferroni’s post test
was performed for all the assays using GraphPad Prism 6
software.
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Figure 1. Hemoglobin levels in erythrocytes of stored blood.
Values are expressed as means ± SE from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM); Cur
60 – Curcumin (60mM).
Changes are analyzed by two-way ANOVA followed by
Bonferroni’s Post-test using Graphpad Prism software. P <
0.05 was considered significant. Changes between groups are
represented in upper case, while changes within a group are
represented in lower case. Those not sharing the same letters are
significant.

3.2. Superoxide
The changes in superoxide were significant with storage.
The superoxide levels in the controls decreased by 55%
(days 10, 15, and 20) while in Cur 10 they decreased by
50% (day 5), 100% (days 10 and 15), and 75% (day 20).
Decrements of 50% (Cur 30) and 30% (Cur 60) on day
5 and 85% (Cur 30 and Cur 60) on days 10 and 15 were
observed.
In Cur 10 superoxide levels were higher by 60% on day
0, while the levels were 90% lower on day 10 against the
controls. Cur 30 showed decreases in superoxide levels of
50% (day 5) and 75% (day 10), whereas Cur 60 showed
decreases of 85% (day 10) against the controls; the same
levels were reduced by 50% in Cur 30 and Cur 60 on day 0
against Cur 10 (Figure 2).
3.3. Antioxidant enzymes
3.3.1. SOD
Significant changes in SOD activity were observed in all
groups with storage. Increases by 24% and 39% on days
5 and 15, and 100% increase on day 10 were observed in
the controls (day 0). SOD activity showed amplifications of
75% (day 10) and 40% (day 15) in Cur 10 and 46% (day 5)
in Cur 30. Cur 60 showed 100% increase in SOD on day 5.
Significant changes in SOD activity were observed
in Cur 30 (55% increase on day 5 and 45% decrease on
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Figure 2. Superoxide levels in erythrocytes of stored blood.
Values are expressed as means ± SE from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM);
Cur 60 – Curcumin (60mM). Changes are analyzed by two-way
ANOVA followed by Bonferroni’s post-test using Graphpad
Prism software. P < 0.05 was considered significant. Changes
between groups are represented in upper case, while changes
within a group are represented in lower case. Those not sharing
the same letters are significant.

day 10) against the controls and Cur 10. On day 5, Cur
60 showed increases of 55% against controls and 100%
against Cur 10, and a decrease of 40% on day 10 against
controls and Cur 10 (Figure 3).
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Figure 3. Superoxide dismutase activity in erythrocytes of stored
blood. Values are expressed as means ± SE from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM);
Cur 60 – Curcumin (60mM). Changes are analyzed by two-way
ANOVA followed by Bonferroni’s post-test using Graphpad
Prism software. P < 0.05 was considered significant. Changes
between groups are represented in upper case, while changes
within a group are represented in lower case. Those not sharing
the same letters are significant.
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3.3.2. CAT
Changes in CAT activity with antioxidants and storage
were found to be insignificant between the groups.
Cur 10, Cur 30, and Cur 60 showed decreases of 90% on
days 5 and 10 when compared with the controls (Figure 4).
3.3.3. GSH-Px
GSH-Px activity was found to be insignificant with storage
period.
GSH-Px decreased against the controls by 66% and
42% in Cur 10, 90% and 72% in Cur 30, and 88% and 74%
in Cur 60 on days 10 and 15, respectively. Cur 30 showed
a reduction of 72% in GSH-Px activity on day 5 when
compared with Cur 10 (Figure 5).
3.4. Lipid peroxidation
3.4.1. Conjugate dienes
The levels of conjugate dienes changed significantly with
storage. Conjugate dienes decreased in controls (40% on
days 10 and 15), Cur 10 (30% on day 5 and 50% on days 10
and 15), Cur 30 (40% on days 10 and 15), and Cur 60 (60%
on days 10 and 15).
Conjugate dienes decreased against the controls by
20% on day 10 in Cur 10, 30% on day 5 and 45% on day
10 in Cur 30, and by 65% on day 10 in Cur 60. Cur 30 and
Cur 60 showed decrements of 40% on day 0 against Cur
10 (Figure 6).
3.4.2. MDA
MDA was assayed as a measure of lipid peroxidation
and significant changes were observed during storage.
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Figure 4. Catalase activity in erythrocytes of stored blood. Values
are expressed as means ± SE from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM);
Cur 60 – Curcumin (60mM). Changes are analyzed by two-way
ANOVA followed by Bonferroni’s post-test using Graphpad
Prism software. P < 0.05 was considered significant. Changes
between groups are represented in upper case, while changes
within a group are represented in lower case. Those not sharing
the same letters are significant.
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Figure 5. Glutathione peroxidase activity in erythrocytes of
stored blood. Values are expressed as means ± SE from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM);
Cur 60 – Curcumin (60mM). Changes are analyzed by two-way
ANOVA followed by Bonferroni’s post-test using Graphpad
Prism software. P < 0.05 was considered significant. Changes
between groups are represented in upper case, while changes
within a group are represented in lower case. Those not sharing
the same letters are significant.
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Figure 6. Lipid peroxidation in erythrocytes of stored blood in
terms of conjugate dienes. Values are expressed as means ± SE
from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM);
Cur 60 – Curcumin (60mM). Changes are analyzed by two-way
ANOVA followed by Bonferroni’s post-test using Graphpad
Prism software. P < 0.05 was considered significant. Changes
between groups are represented in upper case, while changes
within a group are represented in lower case. Those not sharing
the same letters are significant.

Controls showed decreases of 10% on day 5. MDA in Cur
10 increased by 300% (days 5, 10, and 15) and in Cur 30 by
80% (day 5) and 33% (day 15) with respect to day 0. MDA
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increased by100% on day 5, but decreased by 50% on day
15 and 25% on day 10 in Cur 60.
A decrement of 75% (day 0) was observed in Cur 10,
while an increment of 90% (day 5) was observed in Cur 30
against the controls. MDA in Cur 60 aggravated by 80% on
day 5 and decreased by 70% on day 15 against the controls.
Cur 30 showed a 2-fold increase in MDA against Cur 10
on day 0. Cur 60 showed 70% reduction in MDA on day
15 against Cur 10 and Cur 30 (Figure 7).
3.5. Protein oxidation
3.5.1. AOPP
Significant changes were observed in AOPP with storage.
Increases of 5-fold (day 5) and 3-fold (days 10 and 15) were
observed in controls. AOPP decreased by 45% on all days
in Cur 10. In Cur 30 and Cur 60, AOPP levels increased on
day 0 by 30%, while they decreased on days 10 and 15 by
20% in Cur 30 and 35% in Cur 60.
AOPP in Cur 10 increased against the controls by 157%
on day 0 and decreased by 75% (days 5, 10, and 15). On
days 5, 10, and 15, Cur 30 and Cur 60 showed decrements
of 80% against the controls (Figure 8).
3.5.2. P-SH
P-SH was significant in all groups with storage. Controls
showed increments of 63%, 86%, and 100% with
storage on days 5, 10, and 15, respectively. In Cur 10,
P-SH levels decreased by 66% and 27%, while Cur 30
showed increments of 31% and 100% on days 10 and 15,
respectively.
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Figure 7. Lipid peroxidation in erythrocytes of stored blood in
terms of malondialdehyde. Values are expressed as means ± SE
from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM);
Cur 60 – Curcumin (60mM). Changes are analyzed by two-way
ANOVA followed by Bonferroni’s post-test using Graphpad
Prism software. P < 0.05 was considered significant. Changes
between groups are represented in upper case, while changes
within a group are represented in lower case. Those not sharing
the same letters are significant.
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Figure 8. Protein oxidation in erythrocytes of stored blood
in terms of advanced oxidation protein products. Values are
expressed as means ± SE from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM);
Cur 60 – Curcumin (60mM). Changes are analyzed by two-way
ANOVA followed by Bonferroni’s post-test using Graphpad
Prism software. P < 0.05 was considered significant. Changes
between groups are represented in upper case, while changes
within a group are represented in lower case. Those not sharing
the same letters are significant.

P-SH was higher against the controls in Cur 30 (2-fold)
and Cur 60 (5-fold) on day 15. On day 15, elevations of
4-fold and 7-fold were observed in Cur 30 and Cur 60
respectively, with respect to Cur 10. P-SH elevated by 80%
on day 15 in Cur 60 against Cur 30 (Figure 9).
3.6. Hemolysis
Significant changes in hemolysis were observed in all
groups with storage. Hemolysis increased by 26%, 46%,
and 65% (all days) in controls during storage. Levels of
hemolysis increased in Cur 10 (35% on days 10 and 15), in
Cur 30 (22% on day 5; 34% on day 10; and 50% on day 15)
and in Cur 60 (35% on day 5; 44% on day 10; and 64% on
day 15) with storage period.
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Figure 9. Protein oxidation in erythrocytes of stored blood in
terms of protein sulfhydryls. Values are expressed as means ± SE
from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM);
Cur 60 – Curcumin (60mM). Changes are analyzed by two-way
ANOVA followed by Bonferroni’s post-test using Graphpad
Prism software. P < 0.05 was considered significant. Changes
between groups are represented in upper case, while changes
within a group are represented in lower case. Those not sharing
the same letters are significant.

The changes within the groups were found to be
insignificant (Table).
4. Discussion
During storage, RBCs undergo structural and functional
changes that may reduce function and viability after
transfusion (48). The storage of erythrocytes away from
their normal physiological environment leads them to
exhibit various changes in relation to their physical and
biochemical characteristics, which in turn reduce survival

Table. Hemolysis expressed as percentage (%).
Groups

Control

Cur 10

Cur 30

Cur 60

Day 5A

25.50 ± 5.09a

18.33 ± 7.64a

32.67 ± 3.36a

44.67 ± 9.39a

Day 10B

45.83 ± 9.82a

42.00 ± 2.00a

43.24 ± 3.16a

53.57 ± 6.37a

Day 15C

64.94 ± 9.39a

43.33 ± 7.60a

58.67 ± 12.37a

73.18 ± 11.55a

Values are expressed as means ± SE from 5 samples.
Cur 10 – Curcumin (10mM); Cur 30 – Curcumin (30mM); Cur 60 – Curcumin (60mM). Changes are analyzed by two-way ANOVA
followed by Bonferroni’s post-test using Graphpad Prism software. P < 0.05 was considered significant. Changes between groups (days)
are represented in upper case, while changes within a group are represented in lower case. Those not sharing the same letters are
significant.
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and optimal functioning. These changes, collectively
known as the red cell storage lesion, are characterized by
changes in morphology, slowed metabolism with decrease
in adenosine triphosphate, acidosis with decrease in
concentration of 2,3-diphosphoglycerate, loss of function
of cation pumps and consequent loss of intracellular
potassium with accumulation of sodium intracellularly,
oxidative damage to proteins, lipid peroxidation, and
vesicle formation (49–54).
Erythrocytes are constantly exposed to a flux of oxygen.
The dissociation of oxyhemoglobin is not a perfect process
and can lead to the generation of superoxide radical
and methemoglobin (metHb). MetHb is usually rapidly
converted back into Hb by metHb reductase. However,
during storage, there is a reduction in the conversion of
metHb into free Hb and increased free iron is released.
The results obtained in our study showed that the addition
of curcumin was beneficial to the erythrocytes and
maintained Hb throughout storage. Curcumin has been
shown to protect Hb from oxidation and oxyhemoglobin
from nitrite-induced oxidation (7,10).
Superoxide radicals are toxic and play an important
role in the ROS cascade and its effects in erythrocytes.
These radicals can get continuously oxidized, resulting in
the formation of other ROS, in turn causing damage to
proteins and lipids (55). Erythrocytes contain abundant
Cu-Zn SOD to scavenge the superoxide produced
(56), which was observed in the controls. The samples
showed further decreases in superoxide levels, indicative
of successful assistance of curcumin in eliminating
superoxides. This result was corroborated by our previous
results on ROS (57).
The enzymatic antioxidants include the first line of
defense against free radicals in erythrocytes. Curcumin
regulates and modulates the antioxidant enzymes (30–
32) and this was observed in our results of SOD, CAT,
and GSH-Px. The scavenging of superoxide radicals by
curcumin (11,15,16,25) was elucidated by a decrease in
superoxide and SOD in the samples as storage prolonged.
The addition of curcumin assisted the erythrocytes by
scavenging the H2O2 (21) and thereby preventing the
excessive formation of •OH.
The polyunsaturated fatty acids present in erythrocytes
are vulnerable to OS (58). Lipid peroxidation leads to the
production of hydroperoxides and endoperoxides, which
in turn, upon fragmentation, produce reactive carbonyl
species (RCS) in the form of aldehydes such as MDA.
These RCS have far-reaching damaging effects on targets
within and outside membranes (59). The results of the
primary products of lipid peroxidation, i.e. conjugate
dienes, are indicative of the protective effect of curcumin
on lipids. However, as storage progressed, the reduction
in all groups could also be due to the formation of the

secondary products of lipid peroxidation, i.e. MDA. MDA
was maintained in controls with storage, indicating the
efficient antioxidant defense of erythrocytes. However,
curcumin could not scavenge the free radicals efficiently
and inhibit lipid peroxidation completely.
Proteins are also prone to attack by free radicals. Protein
oxidation in erythrocytes is varied and leads to changes
in the erythrocyte membrane, in turn leading to changes
in morphology (60–63). AOPP are formed by the action
of chloraminated oxidants, which produce dityrosine
containing cross-linked protein products (44). AOPP
levels in the groups with additives were much lower than
those in the control group, substantiating that curcumin
was beneficial to proteins. P-SH increased in samples with
higher concentrations of curcumin, indicating that few
free radicals were successfully scavenged by curcumin
(15,16,18–22,25,29); this also indicated the reversibility
of the disulfide groups to reduced SH. Similar results
were observed in plasma from stored blood (64). In
erythrocytes, Band 3, a protein containing six SH groups,
is prone to oxidative damage. Damage to this protein by
oxidation of SH groups to disulfides causes reversible
membrane changes in erythrocytes (65,66). All these
changes are associated with modifications in membrane
properties and in turn, affect the functions and efficiency
of erythrocytes.
Hemolysis increased in all groups during storage
due to lipid peroxidation and redistribution of oxidized
band 3 in the membrane (67). The increase in hemolysis
during storage can be correlated with: 1) results of lipid
peroxidation; and 2) the formation of other products of
protein oxidation, and hence the insufficient protection
by curcumin against those forms of protein oxidation and
lipid peroxidation.
Curcumin could successfully maintain Hb and
modulate the antioxidant enzymes throughout storage.
However, curcumin could not protect all proteins and lipids
from oxidative damage completely. This study forms a
benchmark for the possibility of using curcumin in storage
solutions. Further studies on curcumin, in combination
with other antioxidants, need to be explored to prevent
oxidative damage during storage. This would form the
basis for development of effective storage solutions, and
thereby prolong the shelf life of erythrocytes.
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